# STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges

> **NCT00654537** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5625 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin
- **DRUG:** Pravastatin
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00654537
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 5625 (ESTIMATED)
- **Last updated:** 2009-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654537, "STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00654537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*